Bevacizumab revisited: its use in different mouse models of ocular pathologies.
about
Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy.Mobile Laser Indirect Ophthalmoscope: For the Induction of Choroidal Neovascularization in a Mouse Model.Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair.
P2860
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
@ast
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
@en
type
label
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
@ast
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
@en
prefLabel
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
@ast
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
@en
P2093
P2860
P1433
P1476
Bevacizumab revisited: its use in different mouse models of ocular pathologies.
@en
P2093
Davine Sijnave
Evelien Vandewalle
Ingeborg Stalmans
Karolien Hollanders
Sarah Van de Velde
Tine Van Bergen
P2860
P304
P356
10.3109/02713683.2014.943910
P50
P577
2014-08-12T00:00:00Z